ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 1,360 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $6 | 0.0% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6 | -25.0% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8 | -99.9% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | -60.0% | 1,360 | -56.1% | 0.00% | -50.0% |
| Q2 2022 | $35,000 | -63.2% | 3,100 | -72.4% | 0.00% | -60.0% |
| Q1 2022 | $95,000 | -5.0% | 11,242 | -18.2% | 0.01% | +25.0% |
| Q4 2021 | $100,000 | +132.6% | 13,742 | +708.4% | 0.00% | +100.0% |
| Q3 2021 | $43,000 | -12.2% | 1,700 | -32.0% | 0.00% | 0.0% |
| Q2 2021 | $49,000 | +250.0% | 2,500 | +525.0% | 0.00% | +100.0% |
| Q1 2021 | $14,000 | -26.3% | 400 | -91.8% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | -50.0% | 4,900 | +4.3% | 0.00% | -50.0% |
| Q2 2020 | $38,000 | – | 4,700 | +4600.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 100 | -98.3% | 0.00% | -100.0% |
| Q3 2019 | $30,000 | – | 5,900 | +1866.7% | 0.00% | – |
| Q2 2019 | $0 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |